论文部分内容阅读
近年来发现中分子量物质(MMS)除参予尿毒症的发病外,还与多种疾病的发病机制有关。为探讨血浆中分子含量与肺心病心力衰竭等脏器损害关系。本文对40例肺心病患者血浆中分子进行测定,现将临床实验结果分析报道如下。1 资料与方法 1.1 选择30例正常健康人为对照组,男性16例,女性14例,年龄20～65岁。肺心病人40例,男性23例,女17例,年龄40～68岁。根据患者有无心力衰竭等合并症分组,A组为肺心病无合并症组(25例),
In recent years, the discovery of medium molecular weight substances (MMS) in addition to the incidence of uremia, but also with a variety of disease pathogenesis. To explore the relationship between plasma molecular weight and heart failure and other organ damage of pulmonary heart disease. In this paper, 40 cases of pulmonary heart disease in plasma molecules, the clinical trial results are reported below. 1 Materials and Methods 1.1 Select 30 cases of normal healthy control group, 16 males and 14 females, aged 20 to 65 years. 40 cases of pulmonary heart disease, 23 males and 17 females, aged 40 to 68 years. According to patients with or without heart failure complications such as group A, pulmonary heart disease without complications (25 cases)